Evidence map›Paper›PMID 33965548›Full record

ArticleGenomics2021

Salmonella Typhi acquires diverse plasmids from other Enterobacteriaceae to develop cephalosporin resistance.

Jobin John Jacob, Agila Kumari Pragasam, Karthick Vasudevan, Balaji Veeraraghavan, Gagandeep Kang, Jacob John, Vasant Nagvekar, Ankur Mutreja

Open access · hybridAbstract read
In one paragraph

Article in Genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Emergence of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  7. Article
  8. The dynamics of blaScientific reports · 2024
    Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prevalence of Antimicrobial Resistance Genes inTropical medicine and infectious disease · 2022
    Review
  15. Changing Paradigms in Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2022
    Article
  16. Circulation of Third-Generation Cephalosporin Resistant Salmonella Typhi in Mumbai, India.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  17. Review
  18. The Spread of Antibiotic Resistance Genes In Vivo Model.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Review
  19. Article
  20. Coriander bornePathogens and global health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jobin John JacobDepartment of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Agila Kumari PragasamDepartment of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Karthick VasudevanDepartment of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India. Electronic address: vbalaji@cmcvellore.ac.in.
Gagandeep KangDivision of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Jacob JohnDepartment of Community Health, Christian Medical College, Vellore, Tamil Nadu, India.
Vasant NagvekarDepartment of Physician/Internal Medicine, Lilavati Hospital & Research Centre, Mumbai, India.
Ankur MutrejaDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Christian Medical College · INChristian Medical College & Hospital · INLilavati Hospital & Research Centre · INUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent reports have established the emergence and dissemination of extensively drug resistant (XDR) H58 Salmonella Typhi clone in Pakistan. In India where typhoid fever is endemic, only sporadic cases of ceftriaxone resistant S. Typhi are reported. This study aimed at elucidating the phylogenetic evolutionary framework of ceftriaxone resistant S. Typhi isolates from India to predict their potential dissemination.

methodsFive ceftriaxone resistant S. Typhi isolates from three tertiary care hospitals in India were sequenced on an Ion Torrent Personal Genome Machine (PGM). A core genome single-nucleotide-polymorphism (SNP) based phylogeny of the isolates in comparison to the global collection of MDR and XDR S. Typhi isolates was built. Two of five isolates were additionally sequenced using Oxford Nanopore MinION to completely characterize the plasmid and understand its transmission dynamics within Enterobacteriaceae.

resultsComparative genomic analysis and detailed plasmid characterization indicate that while in Pakistan (4.3.1 lineage I) the XDR trait is associated with bla

conclusionConsidering the selection pressure exerted by the extensive use of ceftriaxone in India, there are potential risks for the occurrence of plasmid transmission events in the predominant H58 lineages. Therefore, continuous monitoring of S. Typhi lineages carrying plasmid-mediated cephalosporin resistant genes is vital not just for India but also globally.

Indexed as

Salmonella typhiTyphoid FeverAnti-Bacterial AgentsCephalosporin ResistanceEnterobacteriaceaeHumansMicrobial Sensitivity TestsPhylogenyPlasmidsAnti-Bacterial AgentsCephalosporin resistanceIndia, H58 lineagesSalmonella TyphiTyphoid feverXDR

Identifiers

PMID33965548
PMCPMC8276774
OpenAlexW3160722871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.